MedTrace Logo

Pharmacokinetics of Teicoplanin in Intensive Care and Haematology Patients

NCT04096092 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2023-01-31

No results posted yet for this study

Summary

Characterize teicoplanin PK in critically ill patients with a specific focus on alterations of exposure due to variability in renal function.

In a prospective, observational, open-label study the investigators aim to define PK of free drug concentrations of teicoplanine in ICU and heamatology patients and define a PK model for Bayesian dose individualization.

Conditions

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Radboud University Medical Center

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-15
Primary Completion
2021-10-19
Completion
2022-12-01

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04096092 on ClinicalTrials.gov